Co-Diagnostics, Inc.
CODX
$0.56
$0.04639.01%
| 09/30/2024 | 06/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 28.43% | -36.25% | |||
| Total Other Revenue | -82.60% | 1,060.25% | |||
| Total Revenue | -75.87% | 467.81% | |||
| Cost of Revenue | 40.22% | -9.55% | |||
| Gross Profit | -85.94% | 947.88% | |||
| SG&A Expenses | 28.12% | -6.89% | |||
| Depreciation & Amortization | 3.81% | 2.33% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 5.22% | -3.64% | |||
| Operating Income | -33.27% | 25.14% | |||
| Income Before Tax | -27.65% | 18.41% | |||
| Income Tax Expenses | 7.77% | -9.65% | |||
| Earnings from Continuing Operations | -27.60% | 18.39% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -27.60% | 18.39% | |||
| EBIT | -33.27% | 25.14% | |||
| EBITDA | -34.63% | 26.06% | |||
| EPS Basic | -26.04% | 19.13% | |||
| Normalized Basic EPS | -32.70% | 26.34% | |||
| EPS Diluted | -26.83% | 19.13% | |||
| Normalized Diluted EPS | -32.70% | 26.34% | |||
| Average Basic Shares Outstanding | 1.23% | 0.94% | |||
| Average Diluted Shares Outstanding | 1.23% | 0.94% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
